Selected article for: "Aedes aegypti mosquito and ZIKV transmission"
Author: Arunachalam Ramaiah; Deisy Contreras; Vineela Gangalapudi; Masumi Sameer Padhye; Jie Tang; Vaithilingaraja Arumugaswami
Title: Dysregulation of Long Non-coding RNA (lncRNA) Genes and Predicted lncRNA-Protein Interactions during Zika Virus Infection
  • Document date: 2016_7_1
    • ID: 2cerplno_2
    Snippet: This polyprotein is proteolytically cleaved into 11 functional peptides of viral structural and nonstructural components. ZIKV was first isolated from a Rhesus monkey in 1947 [4, 5] . The recent adaptation of ZIKV to a human host resulted in several epidemics across the globe [6, 7] . The virus is transmitted by mosquitos and through sexual contact. The major concern is the increasing geographical distribution of mosquito vectors Aedes aegypti, a.....
    Document: This polyprotein is proteolytically cleaved into 11 functional peptides of viral structural and nonstructural components. ZIKV was first isolated from a Rhesus monkey in 1947 [4, 5] . The recent adaptation of ZIKV to a human host resulted in several epidemics across the globe [6, 7] . The virus is transmitted by mosquitos and through sexual contact. The major concern is the increasing geographical distribution of mosquito vectors Aedes aegypti, and Aedes albopictus, which is responsible for ZIKV transmission in humans. Understanding the interaction of ZIKV with its human host is crucial for developing effective vaccines and therapeutic measures.

    Search related documents:
    Co phrase search for related documents
    • effective vaccine and geographical distribution: 1, 2
    • effective vaccine and human host: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • effective vaccine and major concern: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • effective vaccine and mosquito vector: 1, 2, 3, 4
    • effective vaccine and Rhesus monkey: 1
    • effective vaccine and sexual contact: 1, 2
    • effective vaccine and therapeutic measure: 1, 2
    • effective vaccine and therapeutic measure effective vaccine: 1
    • functional peptide and human host: 1
    • geographical distribution and human host: 1, 2, 3
    • geographical distribution and mosquito vector: 1, 2
    • geographical distribution and ZIKV transmission: 1
    • human host and major concern: 1, 2, 3, 4, 5, 6
    • human host and mosquito vector: 1, 2, 3
    • human host and recent adaptation: 1, 2
    • human host and Rhesus monkey: 1, 2
    • human host and sexual contact: 1
    • human host and ZIKV transmission: 1